A N,5-bis(4-chlorophenyl)-3-(propan-2-ylimino)-3,5-dihydrophenazin-2-amine DMF (Drug Master File) is a document detailing the whole manufacturing process of N,5-bis(4-chlorophenyl)-3-(propan-2-ylimino)-3,5-dihydrophenazin-2-amine active pharmaceutical ingredient (API) in detail. Different forms of N,5-bis(4-chlorophenyl)-3-(propan-2-ylimino)-3,5-dihydrophenazin-2-amine DMFs exist exist since differing nations have different regulations, such as N,5-bis(4-chlorophenyl)-3-(propan-2-ylimino)-3,5-dihydrophenazin-2-amine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A N,5-bis(4-chlorophenyl)-3-(propan-2-ylimino)-3,5-dihydrophenazin-2-amine DMF submitted to regulatory agencies in the US is known as a USDMF. N,5-bis(4-chlorophenyl)-3-(propan-2-ylimino)-3,5-dihydrophenazin-2-amine USDMF includes data on N,5-bis(4-chlorophenyl)-3-(propan-2-ylimino)-3,5-dihydrophenazin-2-amine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The N,5-bis(4-chlorophenyl)-3-(propan-2-ylimino)-3,5-dihydrophenazin-2-amine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of N,5-bis(4-chlorophenyl)-3-(propan-2-ylimino)-3,5-dihydrophenazin-2-amine suppliers with USDMF on PharmaCompass.